For example, silencing XRCC2 can block the cell cycle and increase the sensitivity of rectal cancer cells to radiotherapy (Qin 2015), while the overexpression of XRCC2 in colon cancer promotes the proliferation of cancer cells (Xu 2014). Here, XRCC2 is linked to cancer.